CSI Market
Sign In | Register

Monte Rosa Therapeutics Inc (GLUE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GLUE Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Monte Rosa Therapeutics Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GLUE/balance-sheets
https://api.csimarket.com/api/v1/companies/GLUE/fundamentals
https://api.csimarket.com/api/v1/companies/GLUE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent45.18
Restricted Cash4.92
Marketable Securities, Total MA532.55
Cash & Short-term Investments577.00
Other Receivables7.62
Other Current Assets45.08
Prepaid Expense And Other Assets Current4.72
Total Current Assets640.07
Equipment/Property/Plant Net62.33
Other Assets, Noncurrent0.00
Collaboration Receivable Current-
Restricted Cash Noncurrent4.95
Total Assets697.73
Liabilities
Accounts Payable, Current AC3.35
Accrued Liabilities, Current33.41
Deferred Liability and Revenue102.26
Total Current Liabilities62.05
Total Long-term Debt0.00
Defined Benefit Pension Plan, Liabilities, Noncurrent PE5.13
Other liabilities, Noncurrent57.36
Operating Lease Liability Current4.48
Total Liabilities201.52
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,064.44
Retained Earnings / Accumulated Deficit-562.05
Accumulated Other Comprehensive Income-6.19
Other Equity-6.19
Common Stockholder's Equity496.21
Total Stockholder's Equity496.21
Liabilities & Stockholder's Equity697.73
4 historic quarters locked

Sign in to unlock the full Monte Rosa Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Monte Rosa Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-448568

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI